Autopsy report · NCT00247130

Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleeding Ulcer

Cause of deathOther Automatic label, confidence 0.5, unverified. How labels are made.

“Superiority of iv omeprazole to ranitidine has already been proven by others.”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 4
Sponsor: Keio University
Sponsor type: University, hospital or other
Conditions: Peptic Ulcers
Interventions: Omeprazole; Ranitidine
Participants: 0
Sites: 1
Countries: Japan

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.